Delaware
|
23-2908305
|
|
(State or other jurisdiction of Incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
|
☒ |
Accelerated filer
|
☐ |
Non-accelerated filer
|
☐ |
Smaller reporting company
|
☐
|
Emerging growth company
|
☐ |
•
|
Registration Statement No. 333-160329, filed
with the Securities and Exchange Commission (the “SEC”) on June 30, 2009, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of 16,031,010 shares of
common stock, par value $0.0001 per share, of the Company (“Common Stock”) for issuance under the Company’s 2009 Long-Term Incentive Plan (the “2009 LTIP”) and 1,500,000 shares of Common Stock
for issuance under the Company’s 2009 Employee Stock Purchase Plan (the “2009 ESPP”);
|
•
|
Registration Statement No. 333-182238, filed with the SEC on June
20, 2012, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of 29,671,844 shares of Common Stock for issuance under the 2012 Long-Term Incentive Plan (the
“2012 LTIP”) and 1,021,494 shares of Common Stock under the 2009 ESPP;
|
•
|
Registration Statement No. 333-189213, filed with the SEC on June 10, 2013, as amended on June 19, 2020 and further amended on June 14, 2021 relating to the registration of 43,581,606 shares of Common Stock for
issuance under the Company’s 2013 Long-Term Incentive Plan (the “2013 LTIP”);
|
•
|
Registration Statement No. 333-212012, filed with the SEC on June 14, 2016, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of an additional 4,600,000 shares of Common Stock for issuance
under the 2013 LTIP;
|
•
|
Registration Statement No. 333-214529, filed with the SEC on November 9, 2016, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of an additional 800,000 shares of Common Stock for issuance
under the 2013 LTIP;
|
•
|
Registration Statement No. 333-217805, filed with the SEC on May 9, 2017, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of an additional 1,293,500 shares
of Common Stock for issuance under the 2013 LTIP;
|
•
|
Registration Statement No. 333-218905, filed with the SEC on June 22, 2017, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of 7,172,696 shares of
Common Stock for issuance under the Company’s 2017 Long-Term Incentive Plan, as amended on June 13, 2019 (the “2017 LTIP”);
|
•
|
Registration Statement No. 333-225608, filed with the SEC on June 13, 2018, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of an additional 6,100,000 shares
of Common Stock for issuance under the 2017 LTIP;
|
•
|
Registration Statement No. 333-232142, filed with the SEC on June 14, 2019, as amended on June 19, 2020 and further amended on June 14, 2021, relating to the registration of an additional 850,000 shares of Common Stock for issuance
under the 2017 LTIP and 1,000,000 shares of Common Stock for issuance under the Company’s 2019 Employee Stock Purchase Plan;
|
•
|
Registration Statement No. 333-239330, filed with the SEC on June 19, 2020, as amended on June 14, 2021, relating to the registration of an additional 610,705 shares of Common Stock for issuance pursuant to outstanding inducement
awards under the 2017 LTIP and 650,000 shares of Common Stock for issuance under the Company’s 2020 Long-Term Incentive Plan, as amended on February 12, 2021 (the “2020 LTIP”) and an
additional 92,610 shares of Common Stock for issuance pursuant to outstanding inducement awards under the 2020 LTIP;
|
•
|
Registration Statement No. 333-257053, filed with the SEC on June 11, 2021, relating to the registration of 784,910 shares of Common Stock for issuance pursuant to outstanding inducement awards under the 2020
LTIP and 1,466,561 shares of Common Stock for issuance under the Company’s 2021 Long-Term Incentive Plan;
|
•
|
Registration No. 333-135398, filed with the SEC on June 28, 2006, relating to the registration of 500,000 shares of Common Stock for issuance under the Company’s 2001 Employee Stock Purchase Plan (the “2001
ESPP”), including related rights to purchase Series A Junior Participating Preferred Stock and 6,000,000 shares of Common Stock for issuance under the Company’s 2006 Long-Term Incentive Plan, including related rights to purchase Series A
Junior Participating Preferred Stock;
|
•
|
Registration No. 333-204999, filed with the SEC on June 16, 2015, relating to the registration of 987,961 shares of Common Stock for issuance under the Company’s 2009 ESPP;
|
•
|
Registration No. 333-45330, filed with the SEC on September 7, 2000, relating to the registration of 562,325 shares of Common Stock for issuance under the Company’s Amended & Restated 1998 Equity
Compensation Plan;
|
•
|
Registration No. 333-45332, filed with the SEC on September 7, 2000, relating to the registration of 2,000,000 shares of Common Stock for issuance under the Company’s 2000 Equity Compensation Plan;
|
•
|
Registration No. 333-62894, filed with the SEC on June 13, 2001, relating to the registration of 1,000,000 shares of Common Stock for issuance under the Company’s 2001 ESPP, and
|
•
|
Registration No. 333-86350, filed with the SEC on April 16, 2002, relating to the registration of 2,750,000 shares of Common Stock for issuance under the Company’s 2002 Equity Compensation Plan.
|
ARENA PHARMACEUTICALS, INC.
|
||
By:
|
/s/ Margaret Madden
|
|
Margaret Madden
|
||
Vice President and Secretary
|